C.R. Bard and Acacia Settle Disputes Over Implantable Prosthesis Device Patents

October 5, 2015 – Acacia Research Corp. and C.R. Bard, Inc. settled its lawsuits in the United States District Court for the District of New Jersey and the United States District Court for the District of Delaware on October 2, 2015.  The lawsuits related to C.R. Bard allegedly infringing Acacia’s subsidiaries LifePort Sciences LLC and LifeScreen Sciences LLC’s patents for implantable prosthesis devices.  The patents at issue were U.S. Patent No. 6,126,673, entitled: “Vena Cava Filter,” U.S. Patent No. 6,468,290, entitled: “Two-Planar Vena Cava Filter With Self-Centering Capabilities,” U.S. Patent No. 5,836,969, entitled: “Vena Cava Filter,” and U.S. Patent No. 6,673,103, entitled: “Mesh and Stent for Increased Flexibility.”  The settled cases are LifeScreen Sciences LLC v. C.R. Bard Inc. et al., Civil Action No. 1:13-cv-00129 (D. Del) and LifePort Sciences LLC v. C.R. Bard Inc. et al., Civil Action No. 2:14-cv-05513 (D.N.J.).

By: Frederick C. Millett